IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding IGC Pharma, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 23 | 27 | +4 |
| Shares | 2.65M | 2.82M | +170.9K (+6.4%) |
| Value | $827.5K | $1.01M | +$185.9K (+22.5%) |
New holders (4)
Institutions that held IGC Pharma, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 69,996 | $25.0K | 0.00% |
| Jane Street Group, LLC | 46,540 | $16.7K | 0.00% |
| HRT Financial LP | 18,148 | $6.00K | 0.00% |
| DHJJ Financial Advisors, Ltd. | 80 | $29 | 0.00% |
Sold out (0)
Institutions that held IGC Pharma, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
None.